Beth Israel Medical Center honored the Brooklyn division’s 2013 Heart Award recipients with their plaques. From left, Marguerite Corda, RN, VP, Patient Care Services; Ramy Yakobi, M.D., Director, Emergency Medicine; Kevin Molloy, COO; Mildred Gotiangco, RN, Endoscopy; Chaim Bernstein, M.D., CMO; Mereli Llarenas, RN, ICU; Michael Mattia, DPT, Director, Rehab Therapies; Rhona Hetsrony, VP, Operations; and Harris M. Nagler, M.D., Beth Israel President.


Filipino Reporter health columnist Philip S. Chua, M.D., FACS, FPCS, cardiac surgeon emeritus in Las Vegas, was recently in the Philippines for the launching of his novel health book, Let’s Stop “Killing” Our Children, which has been in circulation in the United States, listed in the U.S. Library of Congress since last year.


EAST HANOVER, N.J. — Novartis announced on Jan. 23, 2013 that the U.S. Food and Drug Administration (FDA) has approved Exjade® (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration of at least 5 mg of iron per gram dry weight and a serum ferritin measurement greater than 300 micrograms per liter.


Fil-Ams Nina Caballero (left) and MC Caballero, who love to run in marathons in the West Coast, joined and finished the 13.1-mile race called “The Really Big Free Marathon and Half Marathon” held in Las Vegas on Nov. 3, 2012.

Latest comments